{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:52:23Z","timestamp":1791499943332,"version":"4.3.4"},"reference-count":14,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.cyto.2017.05.003","type":"journal-article","created":{"date-parts":[[2017,5,12]],"date-time":"2017-05-12T09:30:51Z","timestamp":1494581451000},"page":"44-50","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["The local liver ablation with pulsed electric field stimulate systemic immune reaction against hepatocellular carcinoma (HCC) with time-dependent cytokine profile"],"prefix":"10.1016","volume":"93","author":[{"given":"Xinhua","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigang","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengyong","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuning","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danjing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liming","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianwen","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongchun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhui","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shusen","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2017.05.003_b0005","doi-asserted-by":"crossref","DOI":"10.3322\/caac.21338","article-title":"Cancer statistics in China, 2015","author":"Chen","year":"2016","journal-title":"CA Cancer J. Clin."},{"issue":"11","key":"10.1016\/j.cyto.2017.05.003_b0010","first-page":"14765","article-title":"High expression of N-acetyltransferase 10: a novel independent prognostic marker of worse outcome in patients with hepatocellular carcinoma","volume":"8","author":"Zhang","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.cyto.2017.05.003_b0015","article-title":"Clinical outcomes and risk factors of hepatocellular carcinoma treated by liver transplantation: A multi-center comparison of living donor and deceased donor transplantation","author":"Hu","year":"2015","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"issue":"4","key":"10.1016\/j.cyto.2017.05.003_b0020","doi-asserted-by":"crossref","first-page":"673","DOI":"10.4254\/wjh.v7.i4.673","article-title":"Recent advances in multidisciplinary management of hepatocellular carcinoma","volume":"7","author":"Gomaa","year":"2015","journal-title":"World J. Hepatol."},{"issue":"3","key":"10.1016\/j.cyto.2017.05.003_b0025","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/MEG.0000000000000270","article-title":"High local recurrence of early-stage hepatocellular carcinoma after percutaneous thermal ablationin routine clinical practice","volume":"27","author":"Chinnaratha","year":"2015","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"issue":"6","key":"10.1016\/j.cyto.2017.05.003_b0030","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1159\/000439089","article-title":"Complications after radiofrequency ablation of 233 hepatic tumors","volume":"89","author":"Fonseca","year":"2015","journal-title":"Oncology"},{"issue":"5","key":"10.1016\/j.cyto.2017.05.003_b0035","doi-asserted-by":"crossref","first-page":"16233","DOI":"10.1038\/srep16233","article-title":"Electric ablation with irreversible electroporation (IRE) in vital hepatic structures and follow-up investigation","volume":"9","author":"Chen","year":"2015","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.cyto.2017.05.003_b0040","doi-asserted-by":"crossref","first-page":"9851","DOI":"10.1038\/srep09851","article-title":"Preclinical study of locoregional therapy of hepatocellular carcinoma by bioelectric ablation with microsecond pulsed electric fields (\u03bcsPEFs)","volume":"30","author":"Chen","year":"2015","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.cyto.2017.05.003_b0045","doi-asserted-by":"crossref","first-page":"61","DOI":"10.5604\/16652681.1184219","article-title":"Hepatocellular carcinoma \u2264 4 cm treated with radiofrequency ablation with or without percutaneous ethanol injection","volume":"15","author":"Shi","year":"2015","journal-title":"Ann. Hepatol."},{"issue":"1","key":"10.1016\/j.cyto.2017.05.003_b0050","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.canlet.2015.09.020","article-title":"Radiofrequency ablation-combined multimodel therapies for hepatocellular carcinoma: current status","volume":"370","author":"Chen","year":"2016","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.cyto.2017.05.003_b0055","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s00270-010-9964-1","article-title":"Irreversible electroporation of renal cell carcinoma: a first-in-man phase I clinical study","volume":"34","author":"Pech","year":"2011","journal-title":"Cardiovasc. Intervent. Radiol."},{"issue":"15","key":"10.1016\/j.cyto.2017.05.003_b0060","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s12885-015-1189-x","article-title":"The efficacy and safety of irreversible electroporation for the ablation of renal masses: a prospective, human, in-vivo study protocol","volume":"22","author":"Wagstaff","year":"2015","journal-title":"BMC Cancer."},{"issue":"2","key":"10.1016\/j.cyto.2017.05.003_b0065","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00270-014-1049-0","article-title":"Irreversible electroporation (IRE) fails to demonstrate efficacy in a prospective multicenter phase II trial on lung malignancies: the ALICE trial","volume":"38","author":"Ricke","year":"2015","journal-title":"Cardiovasc. Intervent. Radiol."},{"issue":"1","key":"10.1016\/j.cyto.2017.05.003_b0070","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1148\/radiol.11110475","article-title":"US findings after irreversible electroporation ablation: radiologic-pathologic correlation","volume":"262","author":"Appelbaum","year":"2012","journal-title":"Radiology"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466617301242?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466617301242?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T19:00:50Z","timestamp":1535828450000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466617301242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":14,"alternative-id":["S1043466617301242"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2017.05.003","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The local liver ablation with pulsed electric field stimulate systemic immune reaction against hepatocellular carcinoma (HCC) with time-dependent cytokine profile","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2017.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}